In patients with biopsy-proven NAFLD, Machado et al. proved that when increasing the severity of steatosis, leptin progressively increased while adiponectin decreased; moreover, leptin progressively increased with more severe fibrosis [185]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.